Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinogenesis × Immunohistochemistry × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 36 Squamous Cell Carcinoma of Head and Neck 16 Head and Neck Neoplasms 16 Lung Neoplasms 14 Carcinoma, Non-Small-Cell Lung 13 Melanoma 11 Lymphoma, Follicular 10 Colonic Neoplasms 10 Colorectal Neoplasms 9 Breast Neoplasms, Male 9 Pancreatic Neoplasms 8 Lymphoma 8 Rectal Neoplasms 7 Carcinoma, Ovarian Epithelial 7 Unspecified Adult Solid Tumor, Protocol Specific 6 Lymphoma, B-Cell, Marginal Zone 6 Gliosarcoma 6 Glioblastoma 6 Central Nervous System Neoplasms 6 Sarcoma 5 Salivary Gland Neoplasms 5 Prostatic Neoplasms 5 Ovarian Neoplasms 5 Lymphoma, Mantle-Cell 5 Lymphoma, Large-Cell, Anaplastic 5 Lymphoma, Large B-Cell, Diffuse 5 Esophageal Squamous Cell Carcinoma 5 Esophageal Neoplasms 5 Brain Neoplasms 5 Neuroblastoma 4

Interventions

poly ICLC 1 Vinorelbine 1 Poly I-C 1 Pemetrexed 1 Paclitaxel 1 Monatide (IMS 3015) 1 Immunohistochemistry 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 Blood Specimen Collection 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06778538 2025-01-16

HPGD-ccRCC

Lanzhou University Second Hospital

Carcinoma, Renal Cell, Carcinogenesis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡